PART1 and urinary bladder carcinoma: Multiple studies have found that the overexpression of the lncRNA PART1 promoted the infiltration of mononuclear immune cells, prediction to current immune checkpoint gene markers, inhibition of tumor proliferation, promotion of cell apoptosis, and suppression of cell invasion in bladder cancer (Hu et al., 2019).